Senior Consultant, Evidence Synthesis, Indirect Treatment Comparison (ITC) (United States)

Durham, North Carolina, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Healthcare, ConsultingIndustries

Requirements

Candidates should possess a Master's degree or PhD in epidemiology, pharmacology, public health, or biostatistics, or another relevant health science field, and have at least 5 years of experience in evidence synthesis research, preferably in consulting, the pharmaceutical, or healthcare industry, or academia. They must have substantial experience independently conducting meta-analysis and ITC in at least one programming language such as R, STATA, or SAS, and a strong understanding of systematic literature review (SLR) methods and indirect treatment comparison, including network meta-analysis (NMA) and matching-adjusted indirect comparison (MAIC).

Responsibilities

Senior Consultants are responsible for implementing methodologically rigorous evidence synthesis research, overseeing junior staff, and managing overall projects. They will design HTA compliant evidence synthesis studies, manage staff to ensure high quality and timely work, support senior staff on business initiatives, and work effectively across time zones as part of a global team. They will also synthesize data qualitatively and quantitatively, understand client needs and industry requirements, interpret statistical results, and interact with clients. Furthermore, they are expected to deliver project management and deliverable development, and quality check own and others work to ensure minimal typographical errors.

Skills

Evidence Synthesis

Indirect Treatment Comparison (ITC)

Systematic Literature Review (SLR)

Network Meta-Analysis (NMA)

Matching-Adjusted Indirect Comparison (MAIC)

STATA

SAS

HTA

Observational Study Designs

Trial Study Designs

Statistical Analysis

Data Synthesis

Project Management

Client Interaction

Epidemiology

Pharmacology

Public Health

Biostatistics

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free